Literature DB >> 33815848

Pericarditis Caused by Enterococcus faecium with Acute Liver Failure Treated by a Multifaceted Approach including Antimicrobials and Hemoadsorption.

Thomas Köhler1, Mathias W Pletz2, Simon Altmann1, Carmen Kirchner3, Elke Schwier1, Dietrich Henzler1, Günther Winde3, Claas Eickmeyer1.   

Abstract

BACKGROUND: Sepsis and septic shock are still life-threatening diseases with a high mortality rate. We report a complex case of peritonitis with pericarditis and acute liver failure caused by septic shock. Potentially hepatotoxic antibiotic therapy levels were monitored using the liver maximum capacity (LiMAx®) test, and standard treatment was supplemented by adjunctive hemoadsorption with CytoSorb®. Case Presentation. The case features a 29-year-old woman with a history of Crohn's disease and cachexia. Peritonitis caused by Enterococcus faecium was diagnosed later due to an ileum perforation. The hematogenic spread led to pericarditis. In addition, sepsis-related acute liver failure complicated antimicrobial therapy further. The combination of standard therapy, anti-infective medication, and blood purification was associated with inflammation control, hemodynamic stabilization, and a concomitant decrease in vasopressor support. An efficient, sustained reduction in plasma bilirubin levels was achieved while maintaining liver function.
CONCLUSIONS: This case shows how complex infectious diseases with an atypical infectious focus resulting in septic shock can be successfully treated. A combination of antimicrobial (tigecycline and caspofungin) and long-term adjunctive hemoadsorption therapy was administered while hepatotoxic antibiotic medication was monitored by liver function testing.
Copyright © 2021 Thomas Köhler et al.

Entities:  

Year:  2021        PMID: 33815848      PMCID: PMC7987411          DOI: 10.1155/2021/8824050

Source DB:  PubMed          Journal:  Case Rep Crit Care        ISSN: 2090-6420


  22 in total

1.  Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment.

Authors:  V D Dhokia; D Madhavan; A Austin; Craig G Morris
Journal:  J Intensive Care Soc       Date:  2018-05-28

2.  Early report: The use of Cytosorb™ haemabsorption column as an adjunct in managing severe sepsis: initial experiences, review and recommendations.

Authors:  Craig Morris; Lewis Gray; Marco Giovannelli
Journal:  J Intensive Care Soc       Date:  2015-03-18

3.  Liver disease from asymptomatic constrictive pericarditis.

Authors:  Anish A Sheth; Joseph K Lim
Journal:  J Clin Gastroenterol       Date:  2008-09       Impact factor: 3.062

4.  Cytosorb Adsorption During Emergency Cardiac Operations in Patients at High Risk of Bleeding.

Authors:  Kambiz Hassan; Jochen Kannmacher; Peter Wohlmuth; Ulrich Budde; Michael Schmoeckel; Stephan Geidel
Journal:  Ann Thorac Surg       Date:  2019-01-23       Impact factor: 4.330

Review 5.  Acute-on-chronic liver failure: terminology, mechanisms and management.

Authors:  Shiv K Sarin; Ashok Choudhury
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-03       Impact factor: 46.802

6.  Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test.

Authors:  Magnus F Kaffarnik; Johan F Lock; Hannah Vetter; Navid Ahmadi; Christian Lojewski; Maciej Malinowski; Peter Neuhaus; Martin Stockmann
Journal:  Crit Care       Date:  2013-10-31       Impact factor: 9.097

7.  Hemoadsorption by CytoSorb in septic patients: a case series.

Authors:  Klaus Kogelmann; Dominik Jarczak; Morten Scheller; Matthias Drüner
Journal:  Crit Care       Date:  2017-03-27       Impact factor: 9.097

8.  Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Authors:  Alessandro Tomelleri; Giulio Cavalli; Giacomo De Luca; Corrado Campochiaro; Teresa D'Aliberti; Moreno Tresoldi; Lorenzo Dagna
Journal:  Front Immunol       Date:  2018-06-01       Impact factor: 7.561

9.  Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function.

Authors:  M Stockmann; F W R Vondran; R Fahrner; H M Tautenhahn; J Mittler; H Bektas; M Malinowski; M Jara; I Klein; J F Lock
Journal:  BJS Open       Date:  2018-06-14

10.  Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report.

Authors:  Matthias Buechter; Guido Gerken; Dieter P Hoyer; Stefanie Bertram; Jens M Theysohn; Viktoria Thodou; Alisan Kahraman
Journal:  BMC Anesthesiol       Date:  2018-06-20       Impact factor: 2.217

View more
  2 in total

Review 1.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review.

Authors:  Thomas Köhler; Elke Schwier; Janina Praxenthaler; Carmen Kirchner; Dietrich Henzler; Claas Eickmeyer
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

2.  Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock.

Authors:  Thomas Köhler; Elke Schwier; Carmen Kirchner; Günther Winde; Dietrich Henzler; Claas Eickmeyer
Journal:  J Artif Organs       Date:  2021-05-28       Impact factor: 1.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.